MentionFox
Home › funding signals › ARMR Sciences Inc.
Form D · on the record

ARMR Sciences Inc. — Form D filing, August 2025

ARMR Sciences Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-29.

ARMR Sciences Inc. filed a Form D notice of an exempt securities offering with the SEC on August 29, 2025. Its industry group is Biotechnology. It names Collin Gage (Executive Officer, Director), Shon Remich (Executive Officer), Nicholas Jacob (Executive Officer) (SEC Form D, August 29, 2025).

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

5 more Biotechnology raises in New York within 90 days ↓

Is this your company?

Key facts

Run the free check on ARMR Sciences Inc. →

Sell to companies like ARMR Sciences Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

ARMR Sciences Inc.

New Form D on file · 2025-08-29 · the record

$0
raise on the record
D
filing
0
investors in
NEW YORK
based
Open the record →

What the record says

FilingForm D
Filed2025-08-29
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2023
BasedNEW YORK, NEW YORK
CIK2082685
Accession0002082685-25-000001

Pitching, partnering or investing alongside them? See who really runs and owns ARMR Sciences Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind ARMR Sciences Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in New York, filed within 90 days of this one, largest first.

What do you want to do with ARMR Sciences Inc.?

Get the full cited report on ARMR Sciences Inc.

What the filing shows about ARMR Sciences Inc.

  • The filing names 6 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on ARMR Sciences Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives ARMR Sciences Inc.'s address as 12 E 49TH St, New York, NY 10017.

What the filing says

  • Offered: $30,000,000. Sold: nothing yet. Left to sell: $30,000,000. (filing)
  • Investors: 0 had already invested. (filing)
  • Date of first sale: yet to occur. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on ARMR Sciences Inc. See pricing

Is ARMR Sciences Inc. a real, registered company?

ARMR Sciences Inc. is a registered filer with the SEC (CIK 2082685) and has filed since 2025-08-29. 1 filing is on record, the latest on 2025-08-29.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs ARMR Sciences Inc.?

ARMR Sciences Inc.'s Form D of 2025-08-29 names Collin Gage, Shon Remich, Nicholas Jacob and 3 more as its officers, directors or promoters.

Biotechnology · by week

Trailing twelve months. 766 filings in Biotechnology, totalled by week.

Want the whole picture on ARMR Sciences Inc.?

What the filing shows about ARMR Sciences Inc.

  • The filing names 6 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on ARMR Sciences Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on ARMR Sciences Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind ARMR Sciences Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for ARMR Sciences Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/funding/armr-sciences-inc-form-d-25000001
Last updated 2026-10-30
Primary record: SEC filing 1 · SEC filing 2
ARMR Sciences Inc. — SEC Form D filing, August 2025. MentionFox, 2026-10-30. https://mentionfox.com/funding/armr-sciences-inc-form-d-25000001